Lisa A. Hayes
Nessuna posizione attualmente
Storia della carriera di Lisa A. Hayes
Precedenti posizioni note di Lisa A. Hayes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/02/2021 | 01/02/2023 |
| Public Communications Contact | 01/02/2021 | 01/02/2023 | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - | |
| PROQR THERAPEUTICS N.V. | Contatto Relazioni con gli Investitori | 13/12/2018 | - |
| Public Communications Contact | 13/12/2018 | - | |
| CELGENE | Public Communications Contact | - | - |
Formazione di Lisa A. Hayes
| St. Joseph's University | Masters Business Admin |
| New York University | Graduate Degree |
| Seton Hall University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Paesi Bassi | 2 |
Posizioni
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
- Borsa valori
- Insiders
- Lisa A. Hayes
- Esperienza
